XML 24 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes
3 Months Ended
Mar. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes
6. Income Taxes
The Company’s estimated annual effective income tax rates are used to allocate expected annual income tax expense or benefit to interim periods. The rates are the ratio of estimated annual income tax expense or benefit to estimated annual income or loss before income taxes by taxing jurisdiction, excluding significant unusual or infrequent items, the tax effects of statutory rate changes, certain changes in the assessment of the realizability of deferred tax assets, and excess tax benefits or deficiencies related to the vesting of stock-based compensation awards, which are recognized as discrete items in the interim period in which they occur.
The Company’s income tax (expense) benefit differed from the income tax (expense) benefit computed by applying the U.S. federal statutory corporate income tax rate of 21% for the three months ended March 31, 2019 and 2018, to income (loss) before income taxes as follows:
 
 
 Three Months Ended March 31,
 
 
2019
 
2018
 
 
(In thousands)
Income (loss) before income taxes
 

($28,032
)
 

$27,811

Income tax (expense) benefit at the U.S. federal statutory rate
 
5,887

 
(5,840
)
State income tax (expense) benefit, net of U.S. federal income tax benefit
 
248

 
(319
)
Tax deficiencies related to stock-based compensation
 
(1,938
)
 
(2,526
)
Release of valuation allowance
 
179,146

 

(Increase) decrease in valuation allowance due to current period activity
 
(3,938
)
 
8,401

Other
 
(10
)
 
(35
)
Income tax (expense) benefit
 

$179,395

 

($319
)

Deferred Tax Asset Valuation Allowance
The deferred tax asset valuation allowance was $67.7 million and $242.9 million as of March 31, 2019 and December 31, 2018, respectively. Throughout 2018, the Company maintained a full valuation allowance against its deferred tax assets based on its conclusion, considering all available evidence (both positive and negative), that it was more likely than not that the deferred tax assets would not be realized. A significant item of objective negative evidence considered was the cumulative pre-tax loss incurred over the three-year period ended December 31, 2018, primarily due to impairments of proved oil and gas properties recognized in the first three quarters of 2016. As of March 31, 2019, the Company is in a cumulative pre-tax income position. Based on this factor, as well as other positive evidence including projected future taxable income for the current and future years, the Company concluded that it is more likely than not that the deferred tax assets would be realized and released $179.1 million of the valuation allowance, which is recognized as an increase in deferred tax assets and an income tax benefit for the three months ended March 31, 2019.